Moderna's COVID-19 Vaccine Last Phase

Moderna

Hope around the world

 

 

 

 

U.S. pharmaceutical company Moderna(MRNA) has

 

successfully formed antibodies in all of its subjects

 

in an early clinical trial to develop a Corona 19 vaccine.

There is news that the antibody test by Moderna,

 

an American pharmaceutical company,

 

is successful. In early clinical trials

 

for vaccine development,

 

all of the subjects were tested to form antibodies.

According to the test results,

 

none of the applicants showed serious side effects.

However, more than half of the secondary inoculation group

 

 which is likely to be vulnerable to corona19,

 

 showed minor reactions such as aches.

 

 

There are countless people dying of corona.

Since there were no serious side effects

 

 leading to death, it should be done.

 

It is said that some people who have given the vaccine 

 

twice have formed antibodies that neutralize the virus.

 

 

Moderna's vaccine acts as a chemical messenger

 

that directs protein production,

 

which is confirmed to induce the production

 

of proteins such as corona-19. (mRNA-1273)

The principle is to produce protein spikes

 

surrounding the surface of the Corona 19 virus

 

in advance in the body and then generate immunity to them.

 

 

 

 

The Corona 19 virus is known to penetrate

 

cells after being combined with human

 

cells through protein spikes.

Moderna began clinical trials to administer

 

corona 19 vaccine drugs to humans

 

for the first time in the world.

 

Moderna is set to take Phase 3 trials,

 

which is the final stage of the drug release.

I pray that the vaccine, which everyone

 

in the world is waiting for,

 

will be commercialized as soon as soon as possible.

 

 

 

Any country, anyone, will be a hero

 

if you save them from a terrible virus.

Moderna, cheer up.